Medical Director, Oncology

Article

We are recruiting board-certified oncologists for full and part time positions. Responsibilities include leading teams of health professionals, peer-to-peer discussions with physicians, collaborating with clinical content specialists; and opportunity for health services research. This position is for the individual seeking a change in career direction that is both dynamic and challenging.

We are recruiting board-certified oncologists for full and part time positions. Responsibilities include leading teams of health professionals, peer-to-peer discussions with physicians, collaborating with clinical content specialists; and opportunity for health services research. This position is for the individual seeking a change in career direction that is both dynamic and challenging.

 

eviti, Inc. is a leading health IT company implementing solutions to ensure that patients receive high quality care including access to clinical trials.

 

Over 2,000 oncology practices use eviti Connect for automated certification, and eviti Advisor for oncology decision support.

 

Medical Directors report to Arlene Forastiere, M.D.

 

Interested candidates should contact:
Maureen Horstmann, Director of Human Resources
maureen.horstmann@eviti.com, 215-569-0656, ext. 140

 

www.eviti.com

Recent Videos
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.